EHA26: J&J’s multiple myeloma therapies impress with new data

Tuesday, June 16, 2026GlobalData HealthcareView original

New data for Talvey and Tecvayli was presented at the annual meeting as J&J directs its therapies in earlier-line settings.

Read the full article on the original site.